US · THQ
Abrdn Healthcare Opportunities Fund
- Sector
- Financial Services · Asset Management
- Headquarters
- Philadelphia, PA 19103
- Website
- teklacap.com
Price · as of 2024-09-30
$18.56
Market cap 798.2M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $40.37 | +117.51% |
| Intrinsic Value(DCF) | $15.05 | -18.91% |
| Graham-Dodd Method(GD) | $17.36 | -6.49% |
| Graham Formula(GF) | $639.68 | +3,346.56% |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | $7.09 | ||||
| 2016 | $7.45 | $40.98 | $0.00 | $4.85 | $375.97 |
| 2017 | $8.95 | $40.67 | $0.00 | $11.45 | $214.59 |
| 2018 | $9.84 | $23.11 | $0.00 | $11.89 | $7.63 |
| 2019 | $11.15 | $25.71 | $0.00 | $0.00 | $127.95 |
| 2020 | $12.77 | $78.30 | $11.83 | $14.11 | |
| 2021 | $16.35 | $44.73 | $0.00 | $26.98 | $335.64 |
| 2022 | $14.71 | $15.12 | $37.04 | $0.00 | $111.92 |
| 2023 | $13.85 | $29.74 | $0.00 | $6.29 | $29.75 |
| 2024 | $17.82 | $40.37 | $0.00 | $17.36 | $639.68 |
AI valuation
Our deep-learning model estimates Abrdn Healthcare Opportunities Fund's (THQ) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $40.37
- Current price
- $18.56
- AI upside
- +117.51%
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$15.05
-18.91% upside
Graham-Dodd
$17.36
-6.49% upside
Graham Formula
$639.68
+3,346.56% upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| THQ | Abrdn Healthcare Opportun… | $18.56 | 798.2M | +118% | -19% | -6% | +3,347% | 3.89 | 0.78 | 3.86 | 4.40 | 1.51 | 0.78 | 100.00% | 107.03% | 99.20% | 21.34% | 19.25% | 16.96% | 0.24 | 13.66 | — | — | 1.10 | 25781.00% | 13735.00% | 4022.00% | 10.62% | — | 7.37% | 10.62% | 41.30% | 10.62% | 4.40 | 11.51 | 4.71 | 2.95 |
| DLY | DoubleLine Yield Opportun… | $14.68 | 712.56M | +35% | — | — | — | 13.70 | 0.88 | 11.44 | 16.22 | — | 0.88 | 85.10% | 83.51% | 83.51% | 6.39% | 5.92% | 5.20% | 0.17 | 5.60 | 0.51 | 0.51 | 2.52 | -10000.00% | -5541.00% | 5490.00% | 16.75% | 3.56 | 13.57% | 10.23% | 140.10% | 10.23% | 16.22 | 7.07 | 13.54 | 2.45 |
| IGR | CBRE Global Real Estate I… | $4.97 | 752.46M | +323% | -7% | — | — | -11.87 | 0.90 | 15.38 | — | — | 0.90 | 100.00% | 73.26% | -129.53% | -6.86% | 2.77% | -4.88% | 0.48 | 1.57 | 4.78 | 4.78 | — | -14750.00% | -243.00% | -909.00% | 5.15% | 21.28 | 2.99% | 15.67% | -186.10% | 15.67% | 32.29 | 29.85 | 23.66 | 0.84 |
| JQC | Nuveen Credit Strategies … | $4.89 | 722.82M | +365% | -26% | — | +30% | 11.35 | 0.87 | 6.77 | 12.57 | — | 0.87 | 75.45% | 86.11% | 59.65% | 7.81% | 7.20% | 4.69% | 0.59 | — | 0.04 | 0.18 | 5.35 | -4028.00% | 681.00% | 1199.00% | 12.83% | 0.22 | 7.26% | 12.29% | 139.40% | 12.29% | 12.57 | 12.46 | 10.83 | 0.38 |
| THW | Abrdn World Healthcare Fu… | $12.75 | 508.09M | +116% | +1,979,252% | -98% | — | 8.53 | 0.92 | 7.48 | 10.71 | — | 0.92 | 89.10% | 87.72% | 87.72% | 11.04% | 9.13% | 8.85% | 0.24 | 8.05 | 0.79 | 0.66 | 2.18 | -4139.00% | -3317.00% | -3120.00% | 7.22% | 13.63 | 5.63% | 10.96% | 93.50% | 10.96% | 10.71 | 17.39 | 9.40 | 2.79 |
About Abrdn Healthcare Opportunities Fund
Tekla Healthcare Opportunities Fund is a closed ended balanced mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity and fixed income markets across the globe. It seeks to invest in securities of companies operating in the healthcare sector. The fund also invests in pooled investment vehicles. For its fixed income portion, the fund invests in corporate debt securities across the credit rating spectrum. It benchmarks the performance of its portfolio against the S&P 1500 Healthcare Index and S&P 500 Index. Tekla Healthcare Opportunities Fund was formed on April 2, 2014 and is domiciled in the United States.
- CEO
- Daniel R. Omstead
- Employees
- 0
- Beta
- 0.86
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($15.05 ÷ $18.56) − 1 = -18.91% (DCF, example).